Hint mode is switched on Switch off

Cerevel Therapeutics Holdings, ordinary share
US15678U1280, CERE

Add a stock to WL
Choose all Reset all
Cerevel Therapeutics Holdings, сountry — USA
No trading data
Data display in a chart | table
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
from
to
ADD-IN
Cbonds add-in API
bond data api
Authorization required
You need to request access
More than 2,500 records have been found, please specify your request
No data for the selected period

Latest quotes

explore the most comprehensive database

800 000

bonds globally

Over 400

pricing sources

80 000

stocks

9 000

ETF

track your portfolio in the most efficient way
Bond Search
Watchlist
Excel ADD-IN
Get access
×

— Are you looking for the complete & verified bond data?

— We have everything you need:

full data on over 700 000 bonds, stocks & ETFs; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & financial reports; user-friendly interface; available anywhere via Website, Excel Add-in and Mobile app.

Register
×

Why

You will have detailed descriptive & pricing data for 650K bonds, 76K stocks, 8K ETFs
Get full access to the platform from any device & via Cbonds app
Enhance your portfolio management with Cbonds Excel Add-in
Build yield maps, make chart comparison within a click
Don't wait any longer — start using Cbonds today! Register

Issuer

Profile
Cerevel Therapeutics Holdings Inc is a clinical-stage biopharmaceutical company that combines a deep understanding of the biology and neurocircuitry of the brain with advanced chemistry and central nervous system (CNS) receptor pharmacology to discover and develop ...
Cerevel Therapeutics Holdings Inc is a clinical-stage biopharmaceutical company that combines a deep understanding of the biology and neurocircuitry of the brain with advanced chemistry and central nervous system (CNS) receptor pharmacology to discover and develop new therapies.
Show more Hide
  • Issuer
  • Full borrower / issuer name
    Cerevel Therapeutics Holdings Inc
  • Industry
    Pharmaceutical Preparation and Biotechnology

Placement data

  • Placement type
    IPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    CERE
  • Placement
    22.02.2012
  • Lock up period
    180
  • Number of papers
    5,000,000
  • Volume of raised funds
    65 mln USD
  • Final placement price
    13 USD
  • Price change since placement date
    223.85%
  • By capitalization
    305.21 mln USD
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    CERE
  • Placement
    29.07.2015
  • Lock up period
    180
  • Number of papers
    1,200,000
  • Volume of raised funds
    1.56 mln USD
  • Placement share
    16.59%
  • Final placement price
    1.3 USD
  • Price change since placement date
    3,148.46%
  • By capitalization
    9.37 mln USD
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    CERE
  • Placement
    16.12.2015
  • Lock up period
    180
  • Number of papers
    600,000
  • Volume of raised funds
    0.24 mln USD
  • Placement share
    6.36%
  • Final placement price
    0.4 USD
  • Price change since placement date
    10,425%
  • By capitalization
    3.77 mln USD
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    CERE
  • Placement
    02.07.2021
  • Lock up period
    180
  • Number of papers
    14,000,000
  • Volume of raised funds
    350 mln USD
  • Placement share
    9.91%
  • Final placement price
    25 USD
  • Price change since placement date
    68.4%
  • By capitalization
    3,533.13 mln USD
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    CERE
  • Placement
    12.08.2022
  • Lock up period
    180
  • Number of papers
    7,250,000
  • Volume of raised funds
    253.75 mln USD
  • Final placement price
    35 USD
  • Price change since placement date
    20.29%
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    CERE
  • Placement
    12.10.2023
  • Lock up period
    180
  • Number of papers
    177,103,024
  • Volume of raised funds
    450 mln USD
  • Placement share
    11.14%
  • Final placement price
    22.81 USD
  • Price change since placement date
    84.57%
  • By capitalization
    4,039.72 mln USD
Other placements of the issuer Hide

IFRS/US GAAP reports

2024
I q eng
2023
I q eng
II q eng
III q eng
IV q eng
2022
I q eng
II q eng
III q eng
IV q eng
2021
I q eng
II q eng
III q eng
IV q eng
2020
II q eng
III q eng
IV q eng
Show all Hide
Authorization required
You need to request access

Related Stock indices

Indicators

News

06/12/2023 Cerevel Therapeutics Holdings: Entry Into A Material Definitive Agreement, Regulation Fd Disclosure, Other Events, Financial Statements And Exhibits
01/11/2023 Cerevel Therapeutics Holdings: Results Of Operations And Financial Condition, Financial Statements And Exhibits
11/10/2023 Cerevel Therapeutics Holdings: Of This Current Report Is Incorporated By Reference Into This Item 7.01
02/08/2023 Cerevel Therapeutics Holdings: Results Of Operations And Financial Condition, Financial Statements And Exhibits
07/06/2023 Cerevel Therapeutics Holdings: Submission Of Matters To A Vote Of Security Holders
All organization news

Domestic and international bonds of the issuer

Holders

Industry Leaders

Registration is required to get access.